News

One injection per week! Novo Nordisk's new compound preparation Kyinsu has been approved by the European Union On November 26, 2025, Novo Nordi...

Novo Nordisk Amycretin diabetes Phase II Clinical Data Release On November 25, 2025, Novo Nordisk announced that the GLP-1/Amylin double target ago...

GLP-1 Injections 1.General Specification(in stock) (1)API(Pure powder) (2)Tablet (3)Capsule (4)Injection (5)Liquid Drops 2.Customization: We will n...

Lyophilized Semaglutide CAS 910463-68-2 Product Code: BM-2-4-043 English Name: Semaglutide CAS No.: 910463-68-2 Molecular formula: C187H291N45O59 M...

Fosun Pharma GLP-1 drug and Huiruida have reached an exclusive cooperation and licensing agreement On December 9, 2025, Fosun Pharma (600196. SH; 0...

Shuodi Biotech announces phase 2b clinical data on weight loss of small molecule GLP-1 On December 8, 2025, Shuodi Biotechnology announced that the...

Shiyao Group's GLP-1/GIP receptor dual directional agonist peptide injection (SYH2069 injection) has been approved for clinical use in the Unit...

Franky, a long-term customer from Indonesia, has seen good results using our products. Therefore, based on his requirements, he has repurchased new...

Enclomiphene citrate , a non-steroidal selective estrogen receptor modulator (SERM), has emerged as a promising therapeutic agent for men with seco...

The development of semaglutide originated from in-depth research on the natural hormone GLP-1. In the 1980s, scientists discovered that GLP-1 is se...

NAD+ (Nicotinamide Adenine Dinucleotide, also known as nicotinamide adenine di-nucleotide) is a coenzyme compound composed of nicotinamide, ribose,...

Wan choi, a long-standing client familiar with our business processes, proactively inquired about the latest peptide price list and promptly submit...